Bio-Rad Laboratories BIO Income Statement (2009-2026)

NYSE BIO
$377.07 -3.05 (-0.80%)
As of: Sep 9, 2026 · 11:22 AM EDT
Reported Financials

Bio-Rad Laboratories Quarterly Income Statement

Periods 69 quarters
Latest Jun 2026

Bio-Rad Laboratories reported revenue of $651.00M and net income of $371.40M for the quarter ended Jun 2026, down 0.1% year over year. This income statement covers 69 quarters of results from Jun 2009 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Jun2009 Sep2009 Dec2009 Mar2010 Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue
747.00M732.80M700.10M691.10M680.80M730.30M676.80M681.10M632.10M681.20M610.80M638.50M649.70M667.50M585.40M651.60M653.00M693.20M592.10M651.00M
Cost of RevenueCost of Rev
309.61M334.33M297.43M296.07M308.23M333.17M314.43M318.63M296.44M314.81M284.90M283.40M293.80M325.60M279.40M306.30M309.60M348.00M282.70M305.20M
Gross Profit
436.50M399.90M402.60M395.00M372.60M397.10M362.40M362.50M335.70M366.30M325.90M355.10M355.90M342.00M306.00M345.30M343.40M345.20M309.40M345.80M
Operating items
Research & DevelopmentR&D
64.48M58.85M59.53M64.35M66.81M66.21M74.95M65.04M43.53M63.87M66.40M58.90M91.00M79.60M73.50M60.50M71.30M70.30M62.90M61.20M
Selling, General & AdministrativeSG&A
216.15M221.69M196.69M207.79M211.11M212.20M225.55M207.82M201.20M207.12M214.90M194.70M200.40M204.00M208.80M207.70M206.80M221.00M212.40M212.00M
Operating ExpensesOpex
280.63M280.55M256.23M272.14M277.92M278.41M300.50M272.87M244.73M271.00M281.30M253.60M291.40M283.60M282.30M268.20M278.10M291.30M275.30M273.20M
Operating IncomeOp. Inc
156.80M117.89M146.41M122.89M94.65M118.65M61.91M89.62M90.95M95.32M44.60M101.50M64.50M58.30M23.70M77.10M65.30M-118.90M34.10M72.60M
EBIT
156.80M117.89M146.41M122.89M94.65M118.65M61.91M89.62M90.95M95.32M44.60M101.50M64.50M58.30M23.70M77.10M65.30M-118.90M34.10M72.60M
Non-operating items
Non Operating Interest Expenses
0.43M0.36M4.05M10.72M11.66M11.67M12.34M12.34M12.40M12.32M12.30M12.30M12.10M12.20M12.00M12.60M12.30M12.10M12.30M12.10M
Non Operating Investment IncomeNon-Op. Investment Inc.
4,868.66M10.80M-4545.12M-1338.19M-289.00M978.71M-17.52M-1595.44M36.42M324.24M422.20M-2895.40M792.90M-976.50M31.80M334.40M-495.30M1,029.50M-738.20M458.00M
Other Non Operating IncomeOther Non Op Inc.
-2.23M10.07M32.60M6.71M-4.36M2.30M50.43M16.50M20.45M19.10M34.60M18.20M17.90M19.60M37.20M16.20M8.30M28.60M24.20M23.40M
Non Operating IncomeNon Op. Inc.
Net income details
EBT
5,022.23M-2027.10M-4368.03M-1220.20M-207.32M1,091.40M84.83M-1500.43M137.10M428.40M491.10M-2786.30M861.60M-908.90M83.40M414.00M-431.10M929.20M-689.80M542.10M
Tax ProvisionsTaxes
1,094.19M-461.84M-1000.68M-295.09M-44.51M263.59M15.87M-338.18M30.84M78.66M107.20M-620.80M208.40M-193.10M19.40M96.20M-89.20M209.20M-162.70M170.70M
Profit After TaxPAT
3,929.60M-1572.20M-3367.30M-925.10M-162.80M827.70M69.00M-1162.30M106.30M349.70M383.90M-2165.50M653.20M-715.80M64.00M317.80M-341.90M720.00M-527.10M371.40M
Income from Non-Controlling InterestsInc. Minority
Income from Continuing OperationsIncome (Continuing)
3,928.03M-1565.26M-3367.35M-925.11M-162.81M827.81M68.96M-1162.25M106.26M349.74M383.90M-2165.50M653.20M-715.80M64.00M317.80M-341.90M720.00M-527.10M371.40M
Consolidated Net IncomeConsol Net Inc.
3,928.03M-1565.26M-3367.35M-925.11M-162.81M827.81M68.96M-1162.25M106.26M349.74M383.90M-2165.50M653.20M-715.80M64.00M317.80M-341.90M720.00M-527.10M371.40M
Income towards Parent CompanyParent Net Inc
3,928.03M-1565.26M-3367.35M-925.11M-162.81M827.81M68.96M-1162.25M106.26M349.74M383.90M-2165.50M653.20M-715.80M64.00M317.80M-341.90M720.00M-527.10M371.40M
Net Income towards Common StockholdersNet Income
3,928.03M-1565.26M-3367.35M-925.11M-162.81M827.81M68.96M-1162.25M106.26M349.74M383.90M-2165.50M653.20M-715.80M64.00M317.80M-341.90M720.00M-527.10M371.40M
Additional items
EPS (Basic)
131.75-52.47-112.50-31.05-5.4827.792.33-39.593.6511.9713.46-76.2623.37-25.372.2911.67-12.7026.41-19.5513.89
EPS (Diluted)
129.96-51.82-112.50-31.05-5.4827.792.32-39.593.6411.9713.45-76.2623.34-25.372.2911.67-12.7026.39-19.5513.85
Shares Outstanding
29.81M29.83M29.93M29.79M29.73M29.79M29.60M29.36M29.10M29.21M28.52M28.39M27.95M28.21M27.94M27.23M26.92M27.26M26.96M26.75M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
30.22M30.21M29.93M29.79M29.73M29.79M29.75M29.36M29.22M29.21M28.54M28.39M27.98M28.21M27.95M27.23M26.92M27.28M26.96M26.81M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
29.92M29.93M29.94M29.70M29.82M29.60M29.61M29.08M29.15M28.52M28.52M28.20M28.00M28.02M27.21M27.06M26.97M26.99M26.83M26.74M
EBITDA
156.80M117.89M146.41M122.89M94.65M118.65M61.91M89.62M90.95M95.32M44.60M101.50M64.50M58.30M23.70M77.10M65.30M-118.90M34.10M72.60M
Interest ExpensesInt Expense
0.43M0.36M4.05M10.72M11.66M11.67M12.34M12.34M12.40M12.32M12.30M12.30M12.10M12.20M12.00M12.60M12.30M12.10M12.30M12.10M
Tax Rate
21.79%22.78%22.91%24.18%21.47%24.15%18.70%22.54%22.50%18.36%21.83%22.28%24.19%21.25%23.26%23.24%20.69%22.51%23.59%31.49%